Biomagnetic Signals of Intestinal Ischemia II (SQUID)
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Listed as NCT00179036, this observational or N/A phase trial focuses on Ischemia and remains completed. Sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), it has been updated 7 times since 2000, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Jun 2018 — Jan 2021 [monthly]
Completed
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
▶ Show 2 earlier versions
-
May 2017 — Apr 2018 [monthly]
Completed NA
Status: Unknown Status → Completed · Phase: PHASE1 → NA
-
Jan 2017 — May 2017 [monthly]
Unknown Status PHASE1
First recorded
Jan 2000
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Vanderbilt University Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .